Somatostatin and somatostatin receptors are transiently expressed in the immature rat cerebellar cortex but virtually undetectable in the cerebellum of adults. Although somatostatin binding sites have been visualized during the postnatal period in the external granule cell layer, the type of cell that expresses somatostatin receptors has never been identified; thus, the potential function of somatostatin in the developing cerebellum remains unknown. In the present study, we have taken advantage of the possibility of obtaining a culture preparation that is greatly enriched in immature cerebellar granule cells to investigate the presence of somatostatin receptors and the effect of somatostatin on intracellular messengers on cerebellar neuroblasts in primary culture. Autora- Somatostatin also caused a marked reduction of intracellular calcium concentration. These results show the presence of functionally active somatostatin receptors on immature granule cells. Our data suggest the possible involvement of somatostatin in the regulation of proliferation and/or migration of neuroblasts during the development of the cerebellar cortex.
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Somatostatin [somatotropin release-inhibiting factor (SRIF)] is a cyclic tetradecapeptide that was first isolated in ovine hypothalamic extracts from its ability to inhibit growth hormone release (1) . Subsequent studies have shown that SRIF and SRIF receptors (SRIF-R) are widely distributed in the central nervous system of mammals (2-4), and it is now well documented that SRIF acts as both a neuroendocrine factor inhibiting the secretion of several pituitary hormones and a neurotransmitter and/or neuromodulator controlling a wide spectrum of neuronal activities (5) .
In the adult rat, the cerebellum is virtually devoid of SRIF-immunoreactive neurons and SRIF-R (2, 3). Conversely, during development, the occurrence of SRIF and SRIF-R has been demonstrated in the cerebellar cortex (6, 7) . In particular, the presence of SRIF-like immunoreactivity has been visualized in Purkinje cells, Golgi cells, and climbing fibers during early postnatal life (6) . The existence of SRIF in the primordium of the cerebellum has been detected by radioimmunoassay as early as embryonic day 14 (E14) (8) and the expression of the SRIF gene has been demonstrated by in situ hybridization between birth and postnatal day 9 (P9) (9) . Concurrently, high levels of SRIF-R are expressed in the rat and human cerebellum during development (10, 11) . In the rat, SRIF-R are first detectable at E15, reach a maximum between P8 and P13, and gradually vanish from P13 to P23 (12) . Autoradiographic labeling revealed the occurrence of a high concentration of SRIF-R in the external granule cell (EGG) layer (12), a proliferative area that generates the majority of the cerebellar interneurons [i.e., granule, stellate, and basket cells] (13), while the disappearance of both SRIF and SRIF-R at the end of the third week (9, 12) coincides with the cessation of neurogenesis (13) . However, the cellular localization of SRIF-R and the mode ofaction of somatostatin in the cerebellum have never been investigated.
The physiological significance of the transient expression of the somatostatinergic system during histogenesis of the rat cerebellum is currently a matter of speculation. The appearance of SRIF and SRIF-R is chronologically associated with the replication and migration of the stem cells of the EGC layer (9, 12, 13) . Thus, it has been proposed that SRIF may act as a "trophic factor" involved in the regulation of multiplication of the neuroblasts of the EGC layer (14) . However, while SRIF and SRIF agonists have been shown to slow down the growth of various types of human tumors (15) (16) (17) and to inhibit proliferation of tumoral cells (18, 19) , the function of SRIF in the developing brain remains totally unknown.
In the present study, we have used a culture preparation of 8-day-old rat cerebellum to determine the cell type that expresses SRIF-R and to investigate the mechanism of action of somatostatin. We demonstrate that SRIF-R are borne exclusively by immature granule cells, and we show that these receptor sites are negatively coupled to adenylate cyclase activity and intracellular calcium mobilization. These data suggest that, during postnatal life, SRIF regulates histogenesis in the cerebellar cortex. Tyr8]somatostatin-(1-14) was radioiodinated by means of the lactoperoxidase technique as described (20) . The radioligand, 125I-Tyr-[D-Tyr8]somatostatin- (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) , was purified by reverse-phase HPLC on a Zorbax C18 column (25 x 0.4 cm; Merck) by using a gradient of acetonitrile in 0.25 M triethylammonium phosphate buffer at pH 3. The radioiodinated ligand was eluted at 26% acetonitrile. The specific radioactivity was approximately 2000 Ci/mmol (1 Ci = 37 GBq).
MATERIALS AND METHODS
Cell Culture. Granule cell suspensions were prepared from cerebella of P8 Wistar rats as described (21) . The cells were plated (3 x (Fig. 1) .dmmL-observed on immature granule cells (Fig. 1 A-D) , indicating that these cells possess a high density of binding sites. In contrast, the other cell types were not labeled ( Fig. 1 E and   F ). In the presence of 1 ILM SRIF, the labeling of cultured granule cells was totally inhibited (Fig. 1 G and H) .
The evolution of the concentration of SRIF-R on the neuroblasts was studied during 6 days ofculture. Three hours after cell dissociation, SRIF-R were almost undetectable in the culture, suggesting the alteration of SRIF-R by the cell dispersion procedure (Fig. 2) . The concentration of SRIF binding sites increased rapidly and reached a maximum at 1 day ofculture. Then, the level of SRIF-R decreased gradually and disappeared in coincidence with the death of the neuroblasts (Fig. 2) . (Fig. 3A) .
Competition studies using the same radioligand and SRIF as a competitor were carried out with the neuroblasts after 24 hr of culture (Fig. 3B) . The competition curve was monophasic with an IC50 value of 1.91 ± 0.21 nM and a Hill coefficient of 0.90 ± 0.01 (Fig. 3B) .
To determine if these somatostatinergic binding sites represent functional receptors, two different intracellular messengers were studied-i.e., cAMP and calcium. Treatment of immature granule cells with 30 uM forskolin induced a 400-500% stimulation of cAMP levels (Fig. 4A) . SRIF produced a dose-dependent inhibition of forskolin-evoked cAMP production. Half-maximal inhibition occurred at a dose of 10 ,uM. In the presence of 100 nM SRIF, the stimulatory effect of forskolin was reduced by 86%. Pretreatment of cultured granule cells with pertussis toxin for 5 hr completely blocked the inhibitory effect of SRIF on forskolin-evoked cAMP production (Fig. 4B) . DISCUSSION Previous studies had shown that SRIF-R are transiently present in the rat cerebellar cortex during the early postnatal period (7, 12) . The present data show that SRIF-R are expressed by immature granule cells of the cerebellum in primary culture. The Kd values determined by saturation and competition experiments were similar to those measured by means of membrane binding assay in the adult rat brain (3) and in the immature cerebellum (10 The physiological role of SRIF during development of the central nervous system is currently a matter of speculation. It is now well established that SRIF and its agonists are potent inhibitors of cell proliferation in tumoral cell lines (18, 19) and growth of various human neoplasms (15) (16) (17) . In the human pancreatic cancer cell line Mia-PaCa-2, SRIF inhibits epidermal growth factor (EGF)-stimulated cell proliferation (17) . This effect is mediated through activation of a specific tyrosine phosphatase, independent of the EGF receptortyrosine kinase system (28) . In the same way, SRIF seems to slow down the development of some glia-derived brain tumors, the presence of high concentrations of SRIF-R being restricted to differentiated tumors with low malignancy (29) . Recent studies revealed that SRIF also exerts antiproliferative effects on various types of non-neoplastic somatic cells. In particular, SRIF analogs exert a potent inhibitory effect on multiplication of adrenocortical (30) and vascular smooth muscle cells (31) .
We now demonstrate that neuroblasts ofthe rat cerebellum possess functional SRIF-R. These receptors are only expressed in the EGC layer during the proliferative phase and vanish at the end of neurogenesis (12) . These data, together with the presence of transient SRIF-immunoreactive elements during postnatal life, suggest that one of the effects of SRIF is to regulate histogenesis in the cerebellar cortex during development. 
